The BDTT team supports every step of the process from securing intellectual property, negotiating agreements, managing industry collaborations, to helping launch startups. Whether you’re looking to license a breakthrough discovery or co-develop a novel solution, the BDTT team is positioned to enable meaningful partnerships.
We are actively seeking to build on our history of successful collaborations with companies both large and small and are particularly interested in Industry sponsored research/partnerships.

Meet Our Team

Pamela Collingwood, Esq.
Chief Legal and Intellectual Property Officer
Biography
Pamela Collingwood, Esq., joins The Lundquist Institute as Chief Legal and Intellectual Property Officer, leading legal matters across the Institute and overseeing the intellectual property operations of its business development and technology transfer office.
Collingwood brings more than 20 years of legal and leadership experience across healthcare, biomedical research, and technology commercialization. Most recently, she served as Vice President and Senior Deputy General Counsel for Intellectual Property and Commercialization at City of Hope, where she led the institution’s intellectual property legal function, oversaw its patent and trademark portfolios, negotiated complex technology transactions, and advised on emerging areas including artificial intelligence governance and data licensing.
Previously, Collingwood spent more than 15 years at Cedars-Sinai, where her roles included Senior Counsel and Executive Director of Technology Ventures. Her work spanned intellectual property, commercialization, global partnerships, and venture investment. Across these areas, she supported the development of diagnostics, digital health technologies, medical devices, and therapeutics. She also served as General Counsel and Vice President of a Cedars-Sinai-owned venture fund focused on international healthcare technology investments.

Rubayath Mohsen, MS
Assistant Vice President, Business Development and Technology Transfer
Biography
Rubayath Mohsen heads the Business Development & Technology Transfer (BDTT) office at The Lundquist Institute (TLI), overseeing the commercialization of TLI’s intellectual property portfolio, which includes over 840 patents and patent applications across the life sciences and medical device sectors. She leads patent strategy, licensing, and strategic alliances with industry and community partners to advance TLI’s mission of translating science into commercial products. She also supports start-up formation and works in partnership with TLI’s on-campus incubator, BioLabsLA, to drive innovation and entrepreneurship at TLI.
With over 10 years of experience in technology transfer, Ms. Mohsen held positions at The Rockefeller University, Johns Hopkins Tech Ventures, and Columbia University, where she worked across all core functions of a tech transfer office, including IP management, research contract negotiations, licensing, and industry outreach.
Rubayath holds an MSc in Biotechnology from Johns Hopkins University and a BSc in Biomedical Engineering from Boston University. Her research background includes studying radio-sensitizing factors in glioblastoma cancer stem cells and designing a point-of-care sepsis diagnostic microfluidic chip.

Devinder Moudgil, PhD
Officer, Business Development and Technology Transfer
Biography
Devinder manages intellectual property prosecution and tech transfer contracts including MTAs, CDAs, and research agreements to facilitate commercialization efforts at TLI’s BDTT office. Prior to joining the Lundquist Institute, Devinder worked in the Research Partnerships Office and WE-SPARK Health Institute at the University of Windsor, Canada gaining experience in technology transfer and research partnerships.
Devinder was a recipient of the 2020 AUTM Foundation’s Susan Riley Keyes Memorial Fellowship for technology transfer professionals. A scientist by training, Devinder holds a Ph.D. in Oncology from the University of Alberta in Canada. Her research project focused on the function of human Spindly protein during mitosis. Devinder holds a B.Sc. and Master’s in Genomics from Panjab University in India.